Tag: Abbott Lifts 2012 Forecast
Abbott Lifts 2012 Forecast
Abbott Laboratories reported better-than-expected quarterly sales and earnings, fueled by strong demand for its Humira arthritis drug and its wide array of prescription medicines, nutritional products and medical devices. The company earned $1.24 billion, or 78 cents per share, in […]